Work

Magnetite Nanoparticle Development for Targeted Anti-Inflammatory Drug Delivery in Rheumatoid Arthritis

Year: 2025

Type: article

Abstract: Introduction: About one percent of the world's population suffers with rheumatoid arthritis, a degenerative inflammatory disease that gradually destroys joints and causes severe pain and impairment. Because of their biocompatibility, controlled drug release capabilities, and superparamagnetic characteristics, magnetite nanoparticles have become attractive candidates for targeted medication delivery. In order to improve therapy outcomes in RA, this study seeks to create and describe magnetite nanoparticles that can deliver anti-inflammatory medicines to inflamed joints.

Source: Cuestiones de Fisioterapia

DOI: 10.48047/g826qp16

Authors: Vishwa S. Padole, J. B. Veeramalini, Dil Prasad Subba, Ujwala Panditrao Mahale, Ashish Ambadas Sabale, Naresh S. Halke, David Blessing Rani J, Mohammed Khalid, N. Nagi Reddy

Institutions: Raisoni Group of Institutions, Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology, Sharda University, G H Raisoni University, Centurion University of Technology and Management, Sri Devaraj Urs Academy of Higher Education and Research

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4407923849

FWCI:

Cites:

Cited by:

Related to: 10